Article
Disarming mutant p53 oncogenic function.
Pharmacological research - 1 Jan 2014
Girardini Javier E, Marotta Carolina, Del Sal Giannino
Abstract excerpt
In the last decade intensive research has confirmed the long standing hypothesis that some p53 point mutants acquire novel activities able to cooperate with oncogenic mechanisms. Particular attention has attracted the ability of several such mutants to actively promote the development of aggressive and metastatic tumors in vivo. This knowledge opens a new dimension on rational therapy design, suggesting novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
